Key result
Small 3.6-cm renal mass shows aggressive clear cell RCC requiring radical nephrectomy and IVC thrombectomy.
Why the study?
Extensive inferior vena cava tumor thrombus arising from a small renal mass in renal cell carcinoma is distinctly uncommon and not well characterized.
Case Report (n=1)
This case demonstrates that small renal tumors can exhibit highly aggressive biological behavior, including extensive IVC tumor thrombus, necessitating thorough vascular evaluation.
Small renal masses may require vascular imaging; leaves open whether size-based RCC staging needs revision.
Renal cell carcinoma (RCC) commonly demonstrates venous invasion; however, the occurrence of extensive inferior vena cava (IVC) tumor thrombus arising from a small renal mass is distinctly uncommon. We report a case of a 60-year-old female presenting with low backache and weight loss. Contrast-enhanced positron emission tomography-computed tomography revealed a 3.6-cm exophytic left renal mass with fluorodeoxyglucose-avid tumor thrombus extending from the left renal vein into the retrohepatic IVC below the hepatic veins. The patient underwent open left radical nephrectomy with IVC thrombectomy. Histopathology revealed conventional clear cell RCC measuring 4 cm × 3.5 cm × 3 cm with World Health Organization/International Society of Urological Pathology grade 4 features, tumor necrosis, sarcomatoid and rhabdoid differentiation, renal sinus fat invasion, and lymphovascular emboli. The final pathological staging was pT3bN0. This case highlights that tumor size alone may not reflect biological aggressiveness in RCC. Thorough vascular evaluation is essential even in apparently localized small renal tumors.
No takes yet. Share an insight, caveat, or question.
Ravichandran et al. (2026) conducted a case report in Renal cell carcinoma (n=1). Open left radical nephrectomy with IVC thrombectomy was evaluated. Open left radical nephrectomy with IVC thrombectomy for a 3.6-cm renal mass revealed aggressive clear cell RCC (pT3bN0), showing small tumor size does not preclude aggressive biology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: